Historian John Turney takes a look at the best and brightest of this year's rookie class and hands out his awards.

Primary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September ...

Gilead Sciences, Inc. today announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81% (30 out of 37) of participants with primary biliary ...

CPP Investments chief executive John Graham says despite heightened volatility during the quarter, the fund's diversified portfolio delivered stable returns, with positive performance across asset ...